These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 11801567

  • 1. Internalization property of interleukin-4 receptor alpha chain increases cytotoxic effect of interleukin-4 receptor-targeted cytotoxin in cancer cells.
    Kawakami K, Kawakami M, Leland P, Puri RK.
    Clin Cancer Res; 2002 Jan; 8(1):258-66. PubMed ID: 11801567
    [Abstract] [Full Text] [Related]

  • 2. Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapy.
    Kawakami M, Kawakami K, Stepensky VA, Maki RA, Robin H, Muller W, Husain SR, Puri RK.
    Clin Cancer Res; 2002 Nov; 8(11):3503-11. PubMed ID: 12429641
    [Abstract] [Full Text] [Related]

  • 3. Effect of interleukin (IL)-4 cytotoxin on breast tumor growth after in vivo gene transfer of IL-4 receptor alpha chain.
    Kawakami K, Kawakami M, Husain SR, Puri RK.
    Clin Cancer Res; 2003 May; 9(5):1826-36. PubMed ID: 12738741
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Interleukin 4 receptor-directed cytotoxin therapy for human head and neck squamous cell carcinoma in animal models.
    Strome SE, Kawakami K, Alejandro D, Voss S, Kasperbauer JL, Salomao D, Chen L, Maki RA, Puri RK.
    Clin Cancer Res; 2002 Jan; 8(1):281-6. PubMed ID: 11801570
    [Abstract] [Full Text] [Related]

  • 6. Structure, function, and targeting of interleukin 4 receptors on human head and neck cancer cells.
    Kawakami K, Leland P, Puri RK.
    Cancer Res; 2000 Jun 01; 60(11):2981-7. PubMed ID: 10850446
    [Abstract] [Full Text] [Related]

  • 7. Expression and structure of interleukin 4 receptors in primary meningeal tumors.
    Puri S, Joshi BH, Sarkar C, Mahapatra AK, Hussain E, Sinha S.
    Cancer; 2005 May 15; 103(10):2132-42. PubMed ID: 15830341
    [Abstract] [Full Text] [Related]

  • 8. Potent antitumor activity of IL-13 cytotoxin in human pancreatic tumors engineered to express IL-13 receptor alpha2 chain in vivo.
    Kawakami K, Kawakami M, Husain SR, Puri RK.
    Gene Ther; 2003 Jul 15; 10(13):1116-28. PubMed ID: 12808442
    [Abstract] [Full Text] [Related]

  • 9. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4.
    Schnare M, Blum H, Jüttner S, Röllinghoff M, Gessner A.
    J Immunol; 1998 Oct 01; 161(7):3484-92. PubMed ID: 9759868
    [Abstract] [Full Text] [Related]

  • 10. Overexpressed cell surface interleukin-4 receptor molecules can be successfully targeted for antitumor cytotoxin therapy.
    Kawakami K, Kawakami M, Puri RK.
    Crit Rev Immunol; 2001 Oct 01; 21(1-3):299-310. PubMed ID: 11642612
    [Abstract] [Full Text] [Related]

  • 11. Identification and characterization of interleukin-13 receptor in human medulloblastoma and targeting these receptors with interleukin-13-pseudomonas exotoxin fusion protein.
    Joshi BH, Leland P, Puri RK.
    Croat Med J; 2003 Aug 01; 44(4):455-62. PubMed ID: 12950150
    [Abstract] [Full Text] [Related]

  • 12. Expression of high-affinity interleukin 4 receptors on murine sarcoma cells and receptor-mediated cytotoxicity of tumor cells to chimeric protein between interleukin 4 and Pseudomonas exotoxin.
    Puri RK, Ogata M, Leland P, Feldman GM, FitzGerald D, Pastan I.
    Cancer Res; 1991 Jun 01; 51(11):3011-7. PubMed ID: 2032239
    [Abstract] [Full Text] [Related]

  • 13. In vivo expression of the interleukin 4 receptor alpha by astrocytes in epilepsy cerebral cortex.
    Liu H, Prayson RA, Estes ML, Drazba JA, Barnett GH, Bingaman W, Liu J, Jacobs BS, Barna BP.
    Cytokine; 2000 Nov 01; 12(11):1656-61. PubMed ID: 11052816
    [Abstract] [Full Text] [Related]

  • 14. Combined effects of radiation and interleukin-13 receptor-targeted cytotoxin on glioblastoma cell lines.
    Kawakami K, Kawakami M, Liu Q, Puri RK.
    Int J Radiat Oncol Biol Phys; 2005 Sep 01; 63(1):230-7. PubMed ID: 16111594
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy.
    Kioi M, Kawakami M, Shimamura T, Husain SR, Puri RK.
    Cancer; 2006 Sep 15; 107(6):1407-18. PubMed ID: 16902988
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of action of interleukin-13 antagonist (IL-13E13K) in cells expressing various types of IL-4R.
    Kioi M, Kawakami K, Puri RK.
    Cell Immunol; 2004 May 15; 229(1):41-51. PubMed ID: 15331327
    [Abstract] [Full Text] [Related]

  • 17. Investigation of the interleukin (IL)-4/IL-4 receptor system in promyelocytic leukaemia PLB-985 cells during differentiation toward neutrophil-like phenotype: mechanism involved in IL-4-induced SOCS3 protein expression.
    Ratthé C, Girard D.
    Br J Haematol; 2008 Jan 15; 140(1):59-70. PubMed ID: 18005266
    [Abstract] [Full Text] [Related]

  • 18. Characterization of the interleukin-4 receptor complex in human corneal fibroblasts.
    Fukuda K, Fujitsu Y, Kumagai N, Nishida T.
    Invest Ophthalmol Vis Sci; 2002 Jan 15; 43(1):183-8. PubMed ID: 11773030
    [Abstract] [Full Text] [Related]

  • 19. Expression and targeting of interleukin-4 receptor for primary and advanced ovarian cancer therapy.
    Kioi M, Takahashi S, Kawakami M, Kawakami K, Kreitman RJ, Puri RK.
    Cancer Res; 2005 Sep 15; 65(18):8388-96. PubMed ID: 16166317
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-4 receptor expression on AIDS-associated Kaposi's sarcoma cells and their targeting by a chimeric protein comprised of circularly permuted interleukin-4 and Pseudomonas exotoxin.
    Husain SR, Gill P, Kreitman RJ, Pastan I, Puri RK.
    Mol Med; 1997 May 15; 3(5):327-38. PubMed ID: 9205948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.